Logo image of APM

APTORUM GROUP LTD-CLASS A (APM) Stock Overview

USA - NASDAQ:APM - KYG6096M1226 - Common Stock

1.8207 USD
-0.1 (-5.17%)
Last: 9/19/2025, 2:46:18 PM

APM Key Statistics, Chart & Performance

Key Statistics
52 Week High7.49
52 Week Low0.46
Market Cap13.00M
Shares7.14M
Float4.31M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.79
PEN/A
Fwd PE0.03
Earnings (Next)12-18 2025-12-18
IPO12-18 2018-12-18
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


APM short term performance overview.The bars show the price performance of APM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60 80 100

APM long term performance overview.The bars show the price performance of APM in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of APM is 1.8207 USD. In the past month the price increased by 51.18%. In the past year, price decreased by -11.72%.

APTORUM GROUP LTD-CLASS A / APM Daily stock chart

APM Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21 392.85B
AMGN AMGEN INC 13.07 153.43B
GILD GILEAD SCIENCES INC 14.72 141.40B
VRTX VERTEX PHARMACEUTICALS INC 22.75 98.79B
REGN REGENERON PHARMACEUTICALS 13.04 63.09B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 59.44B
ARGX ARGENX SE - ADR 78.98 44.81B
ONC BEONE MEDICINES LTD-ADR 5.86 39.94B
INSM INSMED INC N/A 30.45B
NTRA NATERA INC N/A 24.73B
BNTX BIONTECH SE-ADR N/A 23.21B
BIIB BIOGEN INC 8.92 20.93B

About APM

Company Profile

APM logo image Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The firm's pipeline is also enriched through the co-development of PathsDx Test, a molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, the commercialization arm of the Singapore's Agency for Science, Technology and Research.

Company Info

APTORUM GROUP LTD-CLASS A

17 Hanover Square

London W1S 1BN GB

CEO: Ian Huen

Employees: 3

APM Company Website

APM Investor Relations

Phone: 85239537700

APTORUM GROUP LTD-CLASS A / APM FAQ

What is the stock price of APTORUM GROUP LTD-CLASS A today?

The current stock price of APM is 1.8207 USD. The price decreased by -5.17% in the last trading session.


What is the ticker symbol for APTORUM GROUP LTD-CLASS A stock?

The exchange symbol of APTORUM GROUP LTD-CLASS A is APM and it is listed on the Nasdaq exchange.


On which exchange is APM stock listed?

APM stock is listed on the Nasdaq exchange.


What is APTORUM GROUP LTD-CLASS A worth?

APTORUM GROUP LTD-CLASS A (APM) has a market capitalization of 13.00M USD. This makes APM a Nano Cap stock.


How many employees does APTORUM GROUP LTD-CLASS A have?

APTORUM GROUP LTD-CLASS A (APM) currently has 3 employees.


What are the support and resistance levels for APTORUM GROUP LTD-CLASS A (APM) stock?

APTORUM GROUP LTD-CLASS A (APM) has a support level at 1.71 and a resistance level at 1.99. Check the full technical report for a detailed analysis of APM support and resistance levels.


Is APTORUM GROUP LTD-CLASS A (APM) expected to grow?

The Revenue of APTORUM GROUP LTD-CLASS A (APM) is expected to decline by -78.44% in the next year. Check the estimates tab for more information on the APM EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy APTORUM GROUP LTD-CLASS A (APM) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does APTORUM GROUP LTD-CLASS A (APM) stock pay dividends?

APM does not pay a dividend.


When does APTORUM GROUP LTD-CLASS A (APM) report earnings?

APTORUM GROUP LTD-CLASS A (APM) will report earnings on 2025-12-18.


What is the Price/Earnings (PE) ratio of APTORUM GROUP LTD-CLASS A (APM)?

APTORUM GROUP LTD-CLASS A (APM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.79).


What is the Short Interest ratio of APTORUM GROUP LTD-CLASS A (APM) stock?

The outstanding short interest for APTORUM GROUP LTD-CLASS A (APM) is 7.22% of its float. Check the ownership tab for more information on the APM short interest.


APM Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to APM. When comparing the yearly performance of all stocks, APM is one of the better performing stocks in the market, outperforming 88.29% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

APM Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to APM. Both the profitability and financial health of APM have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

APM Financial Highlights

Over the last trailing twelve months APM reported a non-GAAP Earnings per Share(EPS) of -0.79. The EPS increased by 13.79% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -26.46%
ROE -20.19%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-156.89%
Sales Q2Q%N/A
EPS 1Y (TTM)13.79%
Revenue 1Y (TTM)-100%

APM Forecast & Estimates

For the next year, analysts expect an EPS growth of 8528.57% and a revenue growth -78.44% for APM


Analysts
Analysts80
Price TargetN/A
EPS Next Y8528.57%
Revenue Next Year-78.44%

APM Ownership

Ownership
Inst Owners1.76%
Ins Owners2.57%
Short Float %7.22%
Short Ratio0.02